News
STXS
1.110
0.00%
0.000
Weekly Report: what happened at STXS last week (0928-1002)?
Weekly Report · 5d ago
Weekly Report: what happened at STXS last week (0921-0925)?
Weekly Report · 09/28 09:36
Weekly Report: what happened at STXS last week (0914-0918)?
Weekly Report · 09/21 09:36
Weekly Report: what happened at STXS last week (0907-0911)?
Weekly Report · 09/14 09:38
Weekly Report: what happened at STXS last week (0831-0904)?
Weekly Report · 09/07 09:35
Stereotaxis: A Real Product Story, But The Stock Already Prices In Success
Seeking Alpha · 09/05 14:05
University of Szeged Celebrates Strongest First Month of Robotic Cardiology Program
Barchart · 09/03 06:56
Stereotaxis Secures FDA 510(k) Clearance For GenesisX Robotic Magnetic Navigation System
Benzinga · 08/31 15:09
Weekly Report: what happened at STXS last week (0824-0828)?
Weekly Report · 08/31 09:38
Stereotaxis Is Maintained at Market Outperform by Citizens
Dow Jones · 08/27 14:14
Stereotaxis Price Target Cut to $3.00/Share From $4.00 by Citizens
Dow Jones · 08/27 14:14
Citizens Maintains Market Outperform on Stereotaxis, Lowers Price Target to $3
Benzinga · 08/27 14:05
Stereotaxis price target lowered to $3 from $4 at Citizens
TipRanks · 08/27 09:55
Weekly Report: what happened at STXS last week (0817-0821)?
Weekly Report · 08/24 09:39
Stereotaxis Q2 Widens On Lower Revenue, Higher Expenses; Provides Outlook
NASDAQ · 08/17 10:05
Weekly Report: what happened at STXS last week (0810-0814)?
Weekly Report · 08/17 09:39
Stereotaxis price target lowered to $3 from $4 at Lake Street
TipRanks · 08/17 09:31
Stereotaxis Earnings Call Signals Early Growth Inflection
TipRanks · 08/13 00:07
ISRG's US Procedure Growth Slows: Is ACA Headwind a Temporary Concern?
NASDAQ · 08/12 18:33
Stereotaxis Is Maintained at Buy by TD Cowen
Dow Jones · 08/12 15:32
More
Webull provides a variety of real-time STXS stock news. You can receive the latest news about Stereotaxis Ord through multiple platforms. This information may help you make smarter investment decisions.
About STXS
Stereotaxis, Inc. designs, manufactures, and markets robotic systems, instruments, and information systems for the interventional laboratory. Its proprietary robotic technology, Robotic Magnetic Navigation (RMN), transforms endovascular interventions using precise computer-controlled magnetic fields to directly control the tip of flexible interventional catheters or devices. Its primary products include the Genesis RMN System, the Odyssey Solution, and other related devices. Through its strategic relationships with fluoroscopy system manufacturers, providers of catheters and electrophysiology mapping systems, and other parties, it offers its customers x-ray systems and other accessory devices. It also provides robotic technologies for interventional cardiology and neuro-interventions. The Genesis RMN System is designed to enable physicians to complete more complex interventional procedures by providing image-guided delivery of catheters.